Skip to content
XPR
content.
Press releases
Video
Podcasts
Op-eds
Lists
Guest posts
Author:
Alligator Bioscience
Invitation to Alligator Bioscience’s Earnings Call on 26 August 2026
August 20, 2026
Notice of Extraordinary General Meeting in Alligator Bioscience AB
July 23, 2026
Alligator Discontinues Independent Development of Mitazalimab for a Strategic Refocus on the HLX22 Project, Announces a Rights Issue of Units of Approximately SEK 125.6 Million and Raises Bridge Loans
July 23, 2026
Alligator Announces First Patient Dosed in Investigator-Initiated Study of Intratumoral Mitazalimab in Early-Stage Breast Cancer
July 2, 2026
Alligator Bioscience Comments on Henlius Update on Global Phase 3 Trial with HLX22
June 8, 2026